Background: Relatively little is known about the relationships between medication
adherence and long-term functional outcomes in the treatment of schizophrenia. To extend …

BackgroundThere is equivocal evidence of the effectiveness of adherence therapy in
improving treatment adherence and clinical outcomes for people with schizophrenia …

One of the major clinical problems in the treatment of people with schizophrenia is
suboptimal medication adherence. Most research focusing on determinants of …

Poor adherence limits the effectiveness of antipsychotic treatment in people with psychosis.
The aim of the pragmatic, exploratory, single‐masked trial conducted in the USA was to …

Despite the advances in the treatment of patients with schizophrenia that have occurred
since the introduction of the second-generation (atypical) antipsychotic agents, a leading …

Partial adherence and nonadherence to medication continue to be problems in the
treatment of patients with schizophrenia. Nonadherence to medication has a negative …

Abstract The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) obtained a
sample of 1493 chronic schizophrenia patients. The European First Episode Schizophrenia …

Objectives: This study aimed to prospectively identify the best single predictor and the best
set of predictors of risk for nonadherence with antipsychotic medication in the treatment of …

Objective: The primary objective of this review is to evaluate the strategies used to improve
patient compliance with antipsychotic medication in the treatment of schizophrenia. Data …

The definition and assessment of adherence vary considerably across studies. Increasing
consensus regarding these issues is necessary to improve our understanding of adherence …